Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

556
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
556

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Salvage prostate bed plus elective pelvic node radiation without androgen deprivation therapy.

Journal of cancer research and clinical oncology·2023
Same author

Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation.

European urology oncology·2023
Same author

A Rare Case of Metastatic Hepatocellular Carcinoma to the Hard Palate.

Journal of investigative medicine high impact case reports·2022
Same author

The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis.

Clinical and translational radiation oncology·2022
Same author

Reference Results for Blood Parameter Changes and Recovery after Pelvic Radiation without Chemotherapy.

Hematology reports·2022
Same journal

Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.

American journal of clinical pathology·2026
Same journal

CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.

American journal of clinical pathology·2026
Same journal

Comprehensive multicriteria life cycle assessment of biopsy processing in a surgical pathology department.

American journal of clinical pathology·2026
Same journal

Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma.

American journal of clinical pathology·2026
Same journal

Mismatch repair protein "nonclassic expression loss" pattern in colorectal cancer: an important staining pattern that is not well understood.

American journal of clinical pathology·2026
Same journal

Musculoskeletal pain in medical laboratory personnel: a cross-sectional study.

American journal of clinical pathology·2026
See all related articles

Related Experiment Video

Updated: Dec 5, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

990

Gleason Score Evolution and the Effect on Prostate Cancer Outcomes.

Gregory P Swanson1, Sean Trevathan1, Kendall A P Hammonds1

  • 1Baylor Scott and White Health, Dallas, TX.

American Journal of Clinical Pathology
|October 20, 2020
PubMed
Summary
This summary is machine-generated.

Revised Gleason grading significantly improves prostate cancer outcome predictions. The current system shows better risk stratification for biochemical failure, metastasis, and prostate cancer death after prostatectomy.

Keywords:
Gleason scoreLong-term follow-upPathology revisionRadical prostatectomyStage migration

More Related Videos

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

22.0K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K

Related Experiment Videos

Last Updated: Dec 5, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

990
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

22.0K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K

Area of Science:

  • Urology
  • Oncology
  • Pathology

Background:

  • Gleason grading is crucial for prostate cancer prognostication.
  • Changes in grading guidelines may impact long-term outcome assessments.

Purpose of the Study:

  • To evaluate the impact of revised Gleason grading on long-term outcomes in a prostatectomy cohort.
  • To compare outcomes using contemporary versus historical Gleason scoring.

Main Methods:

  • Retrospective analysis of 581 patients undergoing radical prostatectomy (1985-1995).
  • Specimens were regraded according to current guidelines.
  • Long-term follow-up (16.7 years) assessed biochemical failure, metastatic disease, and prostate cancer death.

Main Results:

  • Revised Gleason grading shifted scores, with fewer patients in lower-risk groups (Gleason ≤6) and more in intermediate-risk groups (Gleason 7).
  • Biochemical failure, metastatic disease, and prostate cancer death decreased across all risk groups with revised grading.
  • The current grading system demonstrates a clear increase in adverse outcomes with each successive grade group.

Conclusions:

  • Revised Gleason scores enhance the prediction of long-term outcomes for prostate cancer patients.
  • The current grading system provides more accurate risk stratification compared to historical methods.
  • Updated Gleason grading facilitates better patient counseling and treatment decisions.